seed
Stage
2020
Founded
1
Investors
About
Pluvia develops small molecule pharmacological chaperone therapies targeting protein misfolding in rare genetic disorders, with a lead program focused on phenylketonuria (PKU).
Explore Pluvia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.